4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001636178-25-000007
CFO AND TREASURER sold 21,000 shares at an average $473.64 ($9,946,544)
- CFO AND TREASURER acquired 21,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
EDGEMOND JAMES · CFO AND TREASURER
Table I: Non-derivative
16 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-24 | Exercise or conversion : show line 1 in the form 10b5-1 | +21,000 | $146.03 | $3,066,630 | 29,142 | D |
| 2025-11-24 | Sale : show line 2 in the form 10b5-1 | −960 | $467.35 | $448,658 | 28,182 | D |
| 2025-11-24 | Sale : show line 3 in the form 10b5-1 | −1,850 | $468.29 | $866,330 | 26,332 | D |
| 2025-11-24 | Sale : show line 4 in the form 10b5-1 | −1,552 | $469.34 | $728,414 | 24,780 | D |
| 2025-11-24 | Sale : show line 5 in the form 10b5-1 | −2,919 | $470.22 | $1,372,575 | 21,861 | D |
| 2025-11-24 | Sale : show line 6 in the form 10b5-1 | −1,971 | $471.88 | $930,076 | 19,890 | D |
| 2025-11-24 | Sale : show line 7 in the form 10b5-1 | −1,788 | $472.73 | $845,233 | 18,102 | D |
| 2025-11-24 | Sale : show line 8 in the form 10b5-1 | −280 | $473.54 | $132,592 | 17,822 | D |
| Open-market sales · 21,000 sh · avg $473.64 · $9,946,544 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-11-24 | Exercise or conversion : show line 17 in the form 10b5-1 Stock Option | −21,000 | $146.03 | 2027-03-15 | 21,000 | 517 | D |
Loading xslF345X05/primarydocument.xml…